Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
48.19
+1.12 (2.38%)
At close: Aug 1, 2025, 4:00 PM
48.33
+0.14 (0.29%)
After-hours: Aug 1, 2025, 7:59 PM EDT
Accolade Stock Forecast
Stock Price Forecast
The 2 analysts that cover Accolade stock have a consensus rating of "Buy" and an average price target of $112, which forecasts a 132.41% increase in the stock price over the next year. The lowest target is $64 and the highest is $160.
Price Target: $112.00 (+132.41%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 17, 2025.
Analyst Ratings
The average analyst rating for Accolade stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 1 |
| Buy | 3 | 3 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 4 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HSBC | HSBC | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 31, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 30, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $105 → $64 | Buy → Hold | Downgrades | $105 → $64 | +32.81% | Apr 17, 2025 |
| UBS | UBS | Strong Sell → Strong Buy Upgrades n/a | Strong Sell → Strong Buy | Upgrades | n/a | n/a | Jan 8, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $156 → $105 | Buy | Maintains | $156 → $105 | +117.89% | Dec 23, 2024 |
Financial Forecast
Revenue This Year
330.82B
from 290.40B
Increased by 13.92%
Revenue Next Year
377.28B
from 330.82B
Increased by 14.04%
EPS This Year
27.09
from 22.63
Increased by 19.72%
EPS Next Year
33.20
from 27.09
Increased by 22.55%
Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 355.6B | 419.5B | 490.4B |
| Avg | 330.8B | 377.3B | 421.4B |
| Low | 309.2B | 336.0B | 370.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 22.5% | 26.8% | 30.0% |
| Avg | 13.9% | 14.0% | 11.7% |
| Low | 6.5% | 1.6% | -1.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 32.01 | 40.78 | 46.86 |
| Avg | 27.09 | 33.20 | 37.37 |
| Low | 24.55 | 28.09 | 30.69 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 41.5% | 50.5% | 41.1% |
| Avg | 19.7% | 22.6% | 12.5% |
| Low | 8.5% | 3.7% | -7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.